The MAB21L2 gene helps guide early development, especially of the eyes, brain, and parts of the face. If it does not work as expected, a person may be born with very small eyes, missing pieces of eye tissue, reduced vision, or other developmental changes. The protein made by this gene helps your cells follow the right steps as tissues form before birth. MAB21L2 is mainly known in medical genetics and has not become a widely recognized public gene.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which do much of the work inside cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look at this topic more closely, you can read more in the LearnHub.
Overview
MAB21L2Gene function
What if the gene works
The MAB21L2 gene helps guide early development, especially in the eyes, brain, and face. It supports how growing cells take on the right roles as tissues and organs form.
Risk
What if the gene does not work
Variants in the MAB21L2 gene are linked to developmental conditions that mainly affect the eyes and, in some people, brain or head development. Effects can range from milder vision differences to more severe eye malformations, depending on the variant.
Treatment
What does that mean for your treatment
No MAB21L2-specific treatment or management approach is currently established. Treatment choices are guided by the person’s symptoms and clinical findings, not by a drug or care pathway linked specifically to the MAB21L2 gene.
Conditions associated with MAB21L2
Gene function
What if the gene works
Before birth, the MAB21L2 gene helps guide how parts of the body take shape. It is most important during early development, when cells are choosing their roles. Understanding how the MAB21L2 gene supports early eye and brain development helps explain its place in normal growth.
The MAB21L2 gene helps early cells follow the body’s building plan. It supports orderly gene activity so tissues form in the right place at the right time.
This gene is especially important during early eye development. It helps shape the tissues that will become the eye as an embryo grows.
The MAB21L2 gene also supports development of parts of the brain and nervous system. It helps some growing cells take on the right roles during this stage.
Its protein helps control which cell instructions are used during development. This gives groups of growing cells the cues they need to become different tissues.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how variants in the MAB21L2 gene affect eye development shows that many disease-causing changes alter conserved parts of the protein, which can change its shape, stability, or breakdown in the cell. Some variants leave part of the protein working, while more disruptive variants can sharply reduce its activity or alter how it interacts with other early developmental signals. Variants with a larger functional effect are often linked to earlier and more pronounced eye differences.
How variants are linked to conditions
Pathogenic variants in the MAB21L2 gene are linked to rare eye development conditions, especially microphthalmia and anophthalmia, in which one or both eyes are unusually small or absent. MAB21L2 gene variants linked to eye conditions can also lead to coloboma, cataracts, and other structural differences in the eye, and some people have additional features such as hearing loss or facial differences.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MAB21L2, risk is mainly tied to whether a disease-causing gene change is present, often inherited from a parent or happening for the first time in the child. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of developing a MAB21L2-related condition.
Inheritance of MAB21L2 variants
The inheritance pattern for MAB21L2-related conditions can differ depending on the specific variant and the condition involved. In some families, variants in the MAB21L2 gene are inherited in an autosomal dominant pattern, which means a child can inherit the condition from one affected parent. In other families, MAB21L2-related conditions follow an autosomal recessive pattern, so a child must inherit one altered copy from each parent. This is the main reason how MAB21L2 variants are inherited is not described by a single pattern for every person.
What does my MAB21L2 result mean for my family?
For MAB21L2, what it means for family members depends on the exact condition and the specific genetic change, because both dominant and recessive patterns have been reported. In some families, a child with a MAB21L2 change may have close relatives who also carry it and could be affected, while in others parents may be healthy carriers. Some dominant cases happen as a new change in the child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
If a person has certain eye differences or a family history, MAB21L2 genetic testing can check for variants using blood or saliva. A lab reads the MAB21L2 gene's DNA and compares it with the usual sequence. Results may find a relevant variant, no clear variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Testing for MAB21L2 may be worth considering when a baby or child is born with major eye development differences, such as very small eyes, missing parts of the eye, or serious vision problems from birth, especially if similar findings run in the family. A result can help confirm the cause and clarify chances for future children.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help support treatment decisions that are better informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the MAB21L2 gene
When should I seek medical advice?
There is no broadly confirmed evidence that changes in this gene affect how medicines work, so questions about symptoms, side effects, or treatment choices are best discussed with your doctor or pharmacist.